Abstract: An ocular delivery system useful for the treatment of glaucoma in subject in need thereof. Especially, a mucoadhesive solid or semisolid ocular delivery system that includes a matrix of preactivated thiomer of hyaluronic acid and one or more anti-glaucoma drugs. The ocular delivery system may be an ocular insert or an ocular film.
Type:
Application
Filed:
August 3, 2022
Publication date:
October 10, 2024
Applicants:
BIOADHESIVE OPHTHALMICS, UNIVERSITÉ DE LORRAINE
Inventors:
Jean CUINE, Boris BIZET, Frédéric LALLEMAND, Jean GARREC, Stéphane GIBAUD, Anne SAPIN-MINET
Abstract: A mucoadhesive solid or semisolid ocular delivery systems that includes a matrix of preactivated thiomers, preferably under the form of ocular inserts or ocular films. The ocular delivery systems are useful for ocular drug delivery for the treatment of ocular diseases. The delivery systems of the invention can also be used for alleviating ocular conditions such as dry eye syndrome.